TELA BIO, INC. (TELA): Price and Financial Metrics
TELA Price/Volume Stats
| Current price | $2.75 | 52-week high | $9.52 |
| Prev. close | $2.78 | 52-week low | $2.54 |
| Day low | $2.71 | Volume | 44,100 |
| Day high | $2.86 | Avg. volume | 178,575 |
| 50-day MA | $3.92 | Dividend yield | N/A |
| 200-day MA | $5.38 | Market Cap | 67.80M |
TELA Stock Price Chart Interactive Chart >
TELA BIO, INC. (TELA) Company Bio
TELA Bio, Inc. is a commercial stage medical technology company. It focuses on designing, developing and marketing of tissue reinforcement materials to address unmet needs in soft tissue reconstruction. The company offers a portfolio of advanced reinforced tissue matrices that improve clinical outcomes and reduce overall costs of care in hernia repair, abdominal wall reconstruction and plastic and reconstructive surgery. TELA Bio was founded by Antony Koblish and Maarten Persenaire on April 17, 2012 and is headquartered in Malvern, PA.
Latest TELA News From Around the Web
Below are the latest news stories about TELA BIO INC that investors may wish to consider to help them evaluate TELA as an investment opportunity.
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)MALVERN, Pa., Dec. 15, 2023 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA Bio") (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's own anatomy, today announced that the Compensation Committee of the Board of Directors of TELA Bio approved inducement grants of restricted stock units covering 20,175 shares of its common stock |
TELA Bio to Take Part in Connecting the DotsMALVERN, Pa., Dec. 05, 2023 (GLOBE NEWSWIRE) -- TELA Bio, Inc. (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's own anatomy, announced today that it took part in a segment in Connecting the Dots, a series of branded films presented by MedTech Europe and including a film produced for them by BBC StoryWorks Commercial Pr |
TELA Bio to Participate in Piper Sandler’s 35th Annual Healthcare ConferenceMALVERN, Pa., Nov. 16, 2023 (GLOBE NEWSWIRE) -- TELA Bio, Inc. (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's own anatomy, today announced that the Company will participate in Piper Sandler’s 35th Annual Healthcare Conference. TELA’s management is scheduled to present at Piper Sandler’s 35th Annual Healthcare Confere |
TELA Bio, Inc. (NASDAQ:TELA) Q3 2023 Earnings Call TranscriptTELA Bio, Inc. (NASDAQ:TELA) Q3 2023 Earnings Call Transcript November 12, 2023 Operator: Good day and thank you for standing by, and welcome to the TELA Bio Third Quarter Earnings Conference Call. At this time, all participants are in a listen-only mode. [Operator Instructions] Please be advised that today’s conference call is being recorded. I […] |
TELA Bio Reports Third Quarter 2023 Financial ResultsMALVERN, Pa., Nov. 09, 2023 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA Bio"), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's own anatomy, today reported financial results for the third quarter ended September 30, 2023. Recent Highlights Revenue of $15.1 million in the third quarter, representing growth of 35% over the third quarter o |
TELA Price Returns
| 1-mo | -32.27% |
| 3-mo | -50.54% |
| 6-mo | -48.79% |
| 1-year | -69.27% |
| 3-year | -77.82% |
| 5-year | N/A |
| YTD | -58.46% |
| 2023 | -42.43% |
| 2022 | -10.16% |
| 2021 | -14.89% |
| 2020 | 16.14% |
| 2019 | N/A |
Loading social stream, please wait...